{"date":"2026-03-25","count":25,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7827-2026-03-25-2131-1mdox08","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-03-25","time":"21:31:07","subject":"代孫公司廣州漢科生物有限公司公告依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定辦理公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-03-25 21:31，「代孫公司廣州漢科生物有限公司公告依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-03-25-2110-6mzk06","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-03-25","time":"21:10:53","subject":"公告本公司董事會決議庫藏股轉讓員工認股基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-03-25 21:10，「公告本公司董事會決議庫藏股轉讓員工認股基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-03-25-2110-1dxuksd","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-03-25","time":"21:10:23","subject":"公告本公司董事會決議初次創新板上市掛牌前辦理現金增資發行新股。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-03-25 21:10，「公告本公司董事會決議初次創新板上市掛牌前辦理現金增資發行新股。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-03-25-2109-xz10a9","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-03-25","time":"21:09:53","subject":"公告本公司新任薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-03-25 21:09，「公告本公司新任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-03-25-2109-xun8fm","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-03-25","time":"21:09:23","subject":"公告本公司董事會通過114年度合併財務報表。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-03-25 21:09，「公告本公司董事會通過114年度合併財務報表。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-03-25-1958-1o623ue","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-03-25","time":"19:58:23","subject":"本公司研發中新藥ABT-101 Phase Ib用以評估於晚期實體腫瘤患者之安全性與耐受性已取得最終臨床試驗報告。","clause":"第9款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-03-25 19:58，「本公司研發中新藥ABT-101 Phase Ib用以評估於晚期實體腫瘤患者之安全性與耐受性已取得最終臨床試驗報告。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-03-25-1838-1howjn","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-25","time":"18:38:20","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-03-25 18:38，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-03-25-1836-10fn4ra","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-25","time":"18:36:32","subject":"公告本公司董事會重大決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-03-25 18:36，「公告本公司董事會重大決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-03-25-1834-11wjw0o","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-25","time":"18:34:43","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-03-25 18:34，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-03-25-1832-5j9yh6","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-03-25","time":"18:32:41","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-03-25 18:32，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-03-25-1744-18hxhhr","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-03-25","time":"17:44:44","subject":"公告本公司受統一證券邀請舉辦線上公開法人說明會","clause":"第12款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-03-25 17:44，「公告本公司受統一證券邀請舉辦線上公開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-03-25-1703-lrkgsj","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-03-25","time":"17:03:10","subject":"公告本公司受統一證券邀請舉辦公開法人說明會","clause":"第12款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-03-25 17:03，「公告本公司受統一證券邀請舉辦公開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-25-1636-92x690","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-25","time":"16:36:27","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-25 16:36，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-25-1632-1ipy30","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-25","time":"16:32:42","subject":"公告本公司董事會決議股利配發基準日","clause":"第14款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-25 16:32，「公告本公司董事會決議股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-25-1617-5j9yh6","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-25","time":"16:17:35","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-25 16:17，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-03-25-1616-lrkgsj","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-03-25","time":"16:16:14","subject":"公告本公司受統一證券邀請舉辦公開法人說明會","clause":"第12款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-03-25 16:16，「公告本公司受統一證券邀請舉辦公開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-03-25-1609-7zlpyo","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-03-25","time":"16:09:07","subject":"公告本公司訂定115年現金增資認股基準日及相關事宜(補充代收款及存儲專戶行庫)","clause":"第9款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-03-25 16:09，「公告本公司訂定115年現金增資認股基準日及相關事宜(補充代收款及存儲專戶行庫)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-03-25-1549-oihymi","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-03-25","time":"15:49:06","subject":"本公司受邀參加櫃買中心舉辦之「櫃買市場業績發表會」","clause":"第12款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-03-25 15:49，「本公司受邀參加櫃買中心舉辦之「櫃買市場業績發表會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-03-25-1525-1sm3lw","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-03-25","time":"15:25:17","subject":"公告本公司114年現金增資股款催繳事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-03-25 15:25，「公告本公司114年現金增資股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-03-25-1522-19wk8sa","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-03-25","time":"15:22:23","subject":"本公司因近期股價價格異常，應櫃買中心要求公布相關資訊，俾便投資人暸解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-03-25 15:22，「本公司因近期股價價格異常，應櫃買中心要求公布相關資訊，俾便投資人暸解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-03-25-1521-ackl7x","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-03-25","time":"15:21:26","subject":"本公司有價證券近期多次達公佈注意交易資訊標準，故公告相關訊息，以利投資人區別暸解","clause":"第53款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-03-25 15:21，「本公司有價證券近期多次達公佈注意交易資訊標準，故公告相關訊息，以利投資人區別暸解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-03-25-1520-1upq4ur","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-03-25","time":"15:20:19","subject":"公告本公司114年現金增資收足股款暨訂定增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-03-25 15:20，「公告本公司114年現金增資收足股款暨訂定增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-03-25-1443-1xnu34j","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-03-25","time":"14:43:19","subject":"本公司受邀參加櫃買中心業績發表會","clause":"第12款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-03-25 14:43，「本公司受邀參加櫃買中心業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-03-25-1442-1wlqw5m","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-25","time":"14:42:42","subject":"公告本公司115年1月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第53款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-03-25 14:42，「公告本公司115年1月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-03-25-0957-1puinh3","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-03-25","time":"09:57:47","subject":"(4166)友霖-澄清媒體報導","clause":"第53款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-03-25 09:57，「(4166)友霖-澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}